TGFB1 and nasopharyngeal carcinoma: To investigate the potential therapeutic implications of targeting the TGF-β pathway in NPC in vitro, we utilized the platforms with a flat bottom to perform a detailed evaluation of the NPC43 cell migration behavior and metastatic potential after the addition of the TGF-β inhibitor.